Showing results (71-80 of 597) with videos related to

Sort By:
Pageof 60
Clinical Neuropharmacology|March 15, 2019
Real-World Experience With VMAT2 InhibitorsNicki Niemann, Joseph Jankovic
Neurology. Clinical Practice|May 29, 2024
Extrapyramidal System/Symptoms/Signs Should Be RetiredAbhishek Lenka, Joseph Jankovic
Journal of Neurology|June 10, 2023
Real-world experience with VMAT2 inhibitors in Tourette syndromeKarim Makhoul, Joseph Jankovic
Drugs|April 20, 2016
Drug-Induced Dyskinesia, Part 2: Treatment of Tardive DyskinesiaDhanya Vijayakumar, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|April 4, 2017
Media hype: Patient and scientific perspectives on misleading medical newsIsrael Robledo, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2002
Secondary paroxysmal dyskinesiasJaishri Blakeley, Joseph Jankovic
Archives of Internal Medicine|July 30, 2003
Neuroprotection in Parkinson diseaseNicole Simpkins, Joseph Jankovic
Nature Reviews. Neurology|June 24, 2015
Dopa-responsive dystonia--clinical and genetic heterogeneitySubhashie Wijemanne, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|August 31, 2006
Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyRamsey Ashour, Joseph Jankovic
Pageof 60